H.R. 2301 (113th): Clinical Trial Cancer Mission 2020 Act
Jun 6, 2013
113th Congress, 2013–2015
Died in a previous Congress
This bill was introduced on June 6, 2013, in a previous session of Congress, but was not enacted.
Tom Reed II
Representative for New York's 23rd congressional district
Read Text »
Last Updated: Jun 6, 2013
Length: 3 pages
About the bill
- Full Title
To amend the Public Health Service Act to enhance the clinical trial registry data bank reporting requirements and enforcement measures.
Legislative action may be ocurring on one of these bills in lieu of or in parallel to action on this bill.
Referred to Committee
Last Action: Jan 28, 2015
- What is a bill?
The “H.R.” in “H.R. 2301” means this is a House of Representatives bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
The bill’s title was written by its sponsor.
2 cosponsors (1R, 1D) (show)
- Committee Assignments
The committee chair determines whether a bill will move past the committee stage.
There have been no votes related to this bill.
- Subject Areas
- Find Similar Bills
Search for similar bills.
Links & tools
Click a format for a citation suggestion:
Civic Impulse. (2015). H.R. 2301 — 113th Congress: Clinical Trial Cancer Mission 2020 Act. Retrieved from https://www.govtrack.us/congress/bills/113/hr2301
“H.R. 2301 — 113th Congress: Clinical Trial Cancer Mission 2020 Act.” www.GovTrack.us. 2013. April 27, 2015 <https://www.govtrack.us/congress/bills/113/hr2301>
|title=H.R. 2301 (113th)
|accessdate=April 27, 2015
|author=113th Congress (2013)
|date=June 6, 2013
|quote=Clinical Trial Cancer Mission 2020 Act